| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/24/1997 | CN1160344A Lyophilizate of Lipid complex of water insoluble camptothecins |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1035923C Method for preparing lipophilic oligosaccharide antibiotics composition |
| 09/23/1997 | US5670637 Binding to target molecules; antibodies |
| 09/23/1997 | US5670626 Allergen-specific human IgA monoclonal antibodies for mucosal administration |
| 09/23/1997 | US5670623 Methods of use of cellulose binding domain proteins |
| 09/23/1997 | US5670617 Nucleic acid conjugates of tat-derived transport polypeptides |
| 09/23/1997 | US5670547 Moisturizing vehicle for topical application of vitamin A acid |
| 09/23/1997 | US5670543 Skin disorders and aging resistance |
| 09/23/1997 | US5670542 Topical application |
| 09/23/1997 | US5670541 Skin treatment with hydroxy acids |
| 09/23/1997 | US5670536 Pharmaceutical composition based on taxoids |
| 09/23/1997 | US5670530 Anti-cancer composition comprising rhodacyanine compound and cyclodextrin |
| 09/23/1997 | US5670490 High aggregate reticular volume for releasing functional compound |
| 09/23/1997 | US5670480 Method of making polymers having specific properties |
| 09/23/1997 | US5670478 Cyclosporins |
| 09/23/1997 | US5670172 Pharmaceutical spheroid formulation |
| 09/23/1997 | US5670169 Alginates and sodium carboxymethyl cellulose for gels |
| 09/23/1997 | US5670168 Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| 09/23/1997 | US5670166 Pharmaceutical formulation and process |
| 09/23/1997 | US5670158 Bisacodyl dosage form |
| 09/23/1997 | US5670151 Method for controlling hyperproliferative diseases |
| 09/23/1997 | CA1339472C Synergic antioxydant mixture |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033919A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same |
| 09/18/1997 | WO1997033908A1 Lytic peptides |
| 09/18/1997 | WO1997033877A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | WO1997033737A1 Method of forming articles and patterning surfaces via capillary micromolding |
| 09/18/1997 | WO1997033632A2 Alginate containing antimicrobial composition |
| 09/18/1997 | WO1997033628A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 09/18/1997 | WO1997033624A1 Microparticles, process for their production, and their use in ultrasound diagnosis |
| 09/18/1997 | WO1997033622A2 Delivery of nucleic acids by porphyrins |
| 09/18/1997 | WO1997033621A1 Pharmaceutical compositions |
| 09/18/1997 | WO1997033618A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/18/1997 | WO1997033611A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033574A1 Sustained-release metal valproate tablets |
| 09/18/1997 | WO1997033565A1 Nucleoside compositions containing paracellular absorption enhancers |
| 09/18/1997 | WO1997033562A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 09/18/1997 | WO1997033559A1 Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 09/18/1997 | WO1997033558A1 Personal care compositions containing a copolymer having hydrophobic, carbon-based grafts |
| 09/18/1997 | WO1997033552A1 Water soluble paclitaxel prodrugs |
| 09/18/1997 | WO1997033531A1 Oral peptide pharmaceutical products |
| 09/18/1997 | WO1997033474A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | WO1997026866A3 Preparations of non-steroidal analgesics |
| 09/18/1997 | WO1997025067A3 Polymers |
| 09/18/1997 | WO1997023607A3 Presentation of antigen, introduced into cells by stimulation of macropinocytosis |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | DE19611769A1 Mikropartikel, Verfahren zu deren Herstellung, sowie deren Verwendung in der Ultraschall Diagnostik Microparticles, methods for their preparation, and their use in ultrasound diagnostics |
| 09/18/1997 | DE19610396A1 Topical analgesic preparations with high di:methyl sulphate content |
| 09/18/1997 | DE19608813A1 Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen Conjugate for influencing protein-protein interactions |
| 09/18/1997 | CA2249011A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 09/18/1997 | CA2248881A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 09/18/1997 | CA2248782A1 Lytic peptides |
| 09/18/1997 | CA2248739A1 Microparticles, process for their production, and their use in ultrasound diagnosis |
| 09/18/1997 | CA2248620A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2248158A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | CA2248076A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 09/18/1997 | CA2247986A1 Alginate containing antimicrobial composition |
| 09/18/1997 | CA2247432A1 Targeting macromolecular prodrugs to t lymphocytes |
| 09/17/1997 | EP0795585A1 Finely divided suspensions of carotenoids or retinoids and process to manufacture them |
| 09/17/1997 | EP0795573A2 Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
| 09/17/1997 | EP0795567A2 Process for preparing hydrosoluble copolymers of at least one hydrosoluble n-vinyllactam and at least one hydrophobic comonomer |
| 09/17/1997 | EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases |
| 09/17/1997 | EP0795329A1 Parenterally injectable piroxicam solutions |
| 09/17/1997 | EP0795324A2 A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids |
| 09/17/1997 | EP0795323A1 Stable gelified composition containing oxygen- and/or water-sensitive lipophilic actives |
| 09/17/1997 | EP0795322A1 Composition thickened with an alkylether of a polysaccharide |
| 09/17/1997 | EP0795321A1 Stable gelified water in oil emulsion |
| 09/17/1997 | EP0795320A1 Stable gelified composition with high electrolyte content |
| 09/17/1997 | EP0795134A1 Stabilized aqueous steroid immunoassay standards |
| 09/17/1997 | EP0795128A2 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
| 09/17/1997 | EP0794802A1 Inclusion complex of a radiohalogenated fatty acid in a cyclodextrin |
| 09/17/1997 | EP0794798A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 09/17/1997 | EP0794796A1 Complexes of dermatan sulfate and drugs, giving improved pharmacokinetics |
| 09/17/1997 | EP0794795A1 Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
| 09/17/1997 | EP0794788A1 Hepatic-directed compounds and reagents for preparation thereof |
| 09/17/1997 | EP0794783A1 Cyclodextrins as suspending agents for pharmaceutical suspensions |
| 09/17/1997 | EP0794777A1 Lubeluzole intravenous solutions |
| 09/17/1997 | EP0794768A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
| 09/17/1997 | EP0794767A1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0707475B1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 09/17/1997 | EP0689423B1 Aerosol formulation containing a diol-diacid derived dispersing aid |
| 09/17/1997 | EP0660704B1 A process for producing suppositories by compression and suppositories obtained by the process |
| 09/17/1997 | EP0648114B1 Liposomes, method of preparing them and their use in the preparation of drugs |
| 09/17/1997 | EP0646001B1 Bioresorbable polymer microspheres free from surface active agents, their preparation and application as drug |
| 09/17/1997 | EP0610357B1 Transdermal therapeutic systems containing crystallization inhibitors |
| 09/17/1997 | EP0590060B1 Orally administrable therapeutic proteins and method of making |
| 09/17/1997 | EP0460020B2 Drug delivery compositions |